[HTML][HTML] A novel mu-delta opioid agonist demonstrates enhanced efficacy with reduced tolerance and dependence in mouse neuropathic pain models

W Lei, RH Vekariya, S Ananthan, JM Streicher - The journal of pain, 2020 - Elsevier
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …

A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.

W Lei, RH Vekariya, S Ananthan, JM Streicher - The Journal of Pain, 2019 - europepmc.org
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …

[HTML][HTML] A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models

W Lei, RH Vekariya, S Ananthan, JM Streicher - The Journal of Pain, 2020 - jpain.org
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …

[HTML][HTML] A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy with Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models

W Lei, RH Vekariya, S Ananthan… - The journal of pain …, 2020 - ncbi.nlm.nih.gov
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …

A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models

W Lei, RH Vekariya, S Ananthan… - The journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …

A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models

W Lei, RH Vekariya, S Ananthan, JM Streicher - 2020 - repository.arizona.edu
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …

A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy with Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models

W Lei, RH Vekariya, S Ananthan, JM Streicher - jpain.org
Figure S1: SRI-22141 Efficaciously Recruits βarr2 in MOR, DOR, and MOR/DOR
Coexpressing Cells. MOR-βarr2EGFP-U2OS (MOR), DOR-βarr2EGFP-U2OS (DOR), and …

A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.

W Lei, RH Vekariya, S Ananthan, JM Streicher - The Journal of Pain, 2019 - europepmc.org
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …

A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models

W Lei, RH Vekariya, S Ananthan… - The journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Numerous studies have demonstrated a physiological interaction between the mu opioid
receptor (MOR) and delta opioid receptor (DOR) systems. A few studies have shown that …